Physician profile
David S Wu
NPI 1871533844
$4,991.26
in general payments reported to CMS, 2019-2025
45 companies · $945 in 2025
The $945 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $333 · 2021: $446 · 2022: $853 · 2023: $781 · 2024: $975 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,621 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,621.20 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $792.04 | 2019-2025 | |
| Astellas Pharma US INC | $577.68 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $335.54 | 2019-2025 | Botox |
| Janssen Biotech, INC. | $315.64 | 2021-2025 | Erleada, Rybrevant, Carvykti |
| Dendreon Pharmaceuticals LLC | $311.59 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $302.01 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $261.54 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $201.49 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $161.62 | 2020-2025 | Keytruda, Lynparza |
| Sun Pharmaceutical Industries INC. | $136.52 | 2019-2025 | Yonsa |
| 180 Medical, INC. | $118.48 | 2019-2025 | |
| Tolmar, INC. | $102.06 | 2024-2025 | Eligard, Jatenzo |
| Myovant Sciences INC. | $101.29 | 2021-2022 | |
| Boston Scientific Corporation | $98.06 | 2019-2025 | General - Erectile Dysfunction |
| Myriad Genetic Laboratories, INC. | $87.54 | 2022-2023 | Prolaris |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.